Home
>
US Stocks
>
AC Immune SA
AC Immune SA
ACIU

AC Immune SA (ACIU)

$6.050.33%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$6.17
Today Low/High
$6.02 / $6.17
52 Week Low/High
$4.42 / $12.61
Market Cap
$438.1M

Company Details

AC Immune SA is a Nasdaq-listed clinical-stage biopharmaceutical company, which aims to become a global leader in Precision Medicine for neurodegenerative diseases. The Company is utilizing two proprietary discovery platforms, SupraAntigenTM and MorphomerTM, to design, discover and develop small molecule and biological therapeutics as well as diagnostic products intended to diagnose, prevent and modify neurodegenerative diseases caused by misfolding proteins. The Company's pipeline features nine therapeutic and three diagnostic product candidates, with five currently in clinical trials. It has collaborations with major pharmaceutical companies including Roche/Genentech, Lilly and Janssen.
Organisation
AC Immune SA
Headquaters
Lausanne, Vaud, Switzerland
Employees
137
Industry
Health Technology
CEO
Andrea Pfeifer

Discover more

Frequently Asked Questions

What is AC Immune SA (ACIU) share price today?

Can Indians buy AC Immune SA (ACIU) shares?

How can I buy AC Immune SA (ACIU) shares from India?

Can Fractional shares of AC Immune SA (ACIU) be purchased?

What are the documents required to start investing in AC Immune SA (ACIU) stocks?

We are a SEBI registered investement advisor